TG Therapeutics reported $3K in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US USD 3K 1000
Abbvie ABBV:US USD 4.17B 57M
Amgen AMGN:US USD 1.75B 159M
Ardelyx ARDX:US USD 3.16M 2.43M
Bayer BAYN:GR EUR 4.77B 521M
Biogen BIIB:US USD 570.9M 101.4M
Corcept Therapeutics CORT:US USD 1.48M 141K
Curis CRIS:US USD 71K 9K
Dynavax Technologies DVAX:US USD 77.49M 16.15M
Gilead Sciences GILD:US USD 1.4B 1000K
Infinity Pharmaceuticals INFI:US USD 429K 15K
Intercept Pharmaceuticals ICPT:US USD 28K 396K
Johnson & Johnson JNJ:US USD 7.76B 29M
Karyopharm Therapeutics KPTI:US USD 1.87M 888K
Novartis NOVN:VX USD 3.84B 180M
Novavax NVAX:US USD 181.76M 252.83M
Ptc Therapeutics PTCT:US USD 10.89M 3.12M
Puma Biotechnology PBYI:US USD 16.84M 4.34M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Roche Holding ROG:VX 8.95B 613M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M